Skip to content

Brief Intervention in At-Risk First-time Mothers

Brief Intervention in At-Risk First-time Mothers

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00230009
Enrollment
100
Registered
2005-09-30
Start date
2004-04-30
Completion date
2007-03-31
Last updated
2013-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Substance Use

Keywords

child abuse, child neglect, substance use, violence exposure, brief intervention

Brief summary

Preliminary controlled trial of a brief intervention designed to reduce child maltreatment risk among low-income pregnant mothers. Foci will include major risk factors for maltreatment, including substance abuse, social isolation, depression, violence exposure, and maladaptive child-rearing attitudes/beliefs.

Interventions

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
Wayne State University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

Pregnant, expecting first child Inclusion Criteria: Receipt of public assistance (e.g., Medicaid, Food Stamps), ability to communicate in English

Exclusion criteria

Frank psychosis or other cognitive impairment

Design outcomes

Primary

MeasureTime frameDescription
Alcohol Use3 month follow-upAlcohol use was measured by looking at frequency of use in past 30 days with the Alcohol Use Disorders Identification Test (AUDIT), reported at the 3 month follow-up. The mean of each the control and intervention group was used. Frequency of use ranged from 0 to 5 for the follow-up sample. Higher scores mean more frequent use of the substance.
Drug Use3 month follow-upDrug use was measured by looking at frequency of use in past 30 days with the Alcohol Use Disorders Identification Test (AUDIT), reported about marijuana use at the 3 month follow-up. The mean of each the assessment only and intervention group was used. Scores ranged from 0 to 13 for the follow-up sample. Higher scores mean more frequent use of the substance.
Child Abuse Potentialbaseline and 3 month follow-upChange score was calculated by taking the follow-up scores on the Brief Child Abuse Potential Inventory (BCAP) and subtracting the baseline score. The possible total score for the BCAP ranges from 0 to 24. Therefore, the possible range of scores for the change calculation (reported below) is -24 to +24. Higher scores indicate higher risk at the follow-up visit (worse outcome).
Treatment Engagementat 3 month follow-upThe number of participants who reported seeking outpatient substance abuse treatment since baseline (either at a treatment facility or through outpatient counseling).

Secondary

MeasureTime frameDescription
Depressionat 3 month follow-upDepression was measured by using the Center for Epidemiologic Studies Depression Scale (CES-D) at the 3 month follow-up. CES-D total scores can range from 0 to 60. Scores at 16 or higher indicate clinical significance. Higher scores represent higher risk for depression.

Countries

United States

Participant flow

Recruitment details

Participants for this phase were recruited from a large prenatal care clinic affiliated with Wayne State University. Participants were either (a) approached while in the waiting area, or (b) identified via a participant database as being willing to be contacted regarding research studies.

Participants by arm

ArmCount
Assessment Only50
Brief Intervention Session50
Total100

Baseline characteristics

CharacteristicBrief Intervention SessionAssessment OnlyTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
50 Participants50 Participants100 Participants
Age Continuous23.6 years
STANDARD_DEVIATION 4.5
22.6 years
STANDARD_DEVIATION 4.4
23.1 years
STANDARD_DEVIATION 4.4
Region of Enrollment
United States
50 participants50 participants100 participants
Sex: Female, Male
Female
50 Participants50 Participants100 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 500 / 50
serious
Total, serious adverse events
0 / 500 / 50

Outcome results

Primary

Alcohol Use

Alcohol use was measured by looking at frequency of use in past 30 days with the Alcohol Use Disorders Identification Test (AUDIT), reported at the 3 month follow-up. The mean of each the control and intervention group was used. Frequency of use ranged from 0 to 5 for the follow-up sample. Higher scores mean more frequent use of the substance.

Time frame: 3 month follow-up

Population: A total of 43 participants returned for follow-up and were the only participants analyzed on this outcome.

ArmMeasureValue (MEAN)Dispersion
Assessment OnlyAlcohol Use1.37 units on a scaleStandard Deviation 1.57
Brief Intervention SessionAlcohol Use0.92 units on a scaleStandard Deviation 1.35
Primary

Child Abuse Potential

Change score was calculated by taking the follow-up scores on the Brief Child Abuse Potential Inventory (BCAP) and subtracting the baseline score. The possible total score for the BCAP ranges from 0 to 24. Therefore, the possible range of scores for the change calculation (reported below) is -24 to +24. Higher scores indicate higher risk at the follow-up visit (worse outcome).

Time frame: baseline and 3 month follow-up

ArmMeasureValue (MEAN)Dispersion
Assessment OnlyChild Abuse Potential-1.8 units on a scaleStandard Deviation 5.8
Brief Intervention SessionChild Abuse Potential-2.4 units on a scaleStandard Deviation 5.7
Primary

Drug Use

Drug use was measured by looking at frequency of use in past 30 days with the Alcohol Use Disorders Identification Test (AUDIT), reported about marijuana use at the 3 month follow-up. The mean of each the assessment only and intervention group was used. Scores ranged from 0 to 13 for the follow-up sample. Higher scores mean more frequent use of the substance.

Time frame: 3 month follow-up

Population: A total of 43 participants returned for follow-up and were the only participants analyzed on this outcome.

ArmMeasureValue (MEAN)Dispersion
Assessment OnlyDrug Use1.89 units on a scaleStandard Deviation 3.6
Brief Intervention SessionDrug Use0.63 units on a scaleStandard Deviation 1.76
Primary

Treatment Engagement

The number of participants who reported seeking outpatient substance abuse treatment since baseline (either at a treatment facility or through outpatient counseling).

Time frame: at 3 month follow-up

ArmMeasureValue (NUMBER)
Assessment OnlyTreatment Engagement0 participants
Brief Intervention SessionTreatment Engagement1 participants
Secondary

Depression

Depression was measured by using the Center for Epidemiologic Studies Depression Scale (CES-D) at the 3 month follow-up. CES-D total scores can range from 0 to 60. Scores at 16 or higher indicate clinical significance. Higher scores represent higher risk for depression.

Time frame: at 3 month follow-up

ArmMeasureValue (MEAN)Dispersion
Assessment OnlyDepression19.74 units on a scaleStandard Deviation 6.2
Brief Intervention SessionDepression20.33 units on a scaleStandard Deviation 6.5

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026